(by Shamard Charles, M.D., NBC News) – The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent warning letters on April 2 to three companies that market CBD products, saying the companies are making false claims about treating diseases such as cancer and Alzheimer’s.
The agencies assert that three companies — Nutra Pure, PotNetwork Holdings, and Advanced Spine and Pain — are falsely advertising the effectiveness of supplements that contain cannabidiol, commonly known as CBD. The products are marketed under names such as “Hemp Oil,” “CBD Softgels,” “CBD for Dogs,” “Liquid Gold Gummies,” and “CBD Oil.”
One company in particular — Nutra Pure — advertises that scientific research supports their claims that their CBD product is an effective anti-seizure medication.
It’s not uncommon to mistake CBD, or cannabidiol, for marijuana. Some fear it will get them “high,” after all, it does come from the cannabis plant. However, the increasingly popular CBD is the non-psychoactive compound found in cannabis that is known to have potential health benefits. It’s sold in a variety of forms from oils to topicals to candies and capsules, and it’s becoming less of a stranger to the Greeley and Windsor communities.
Co-owner of Gold Care CBD in Greeley, Josh Gutierrez says they go through about 200 to 300 bottles of their 680+ Full Spectrum Hemp Extract every week between selling it in store and to local and New York City-based wholesale clients. One 30 milliliter bottle has 680 milligram of full spectrum hemp oil and runs $45 per bottle.